Alwyn Capital

Alwyn Capital Alwyn Capital, founded in 2018 in Brooklyn, New York, pursues a thesis that sounds simple but has deep biotech implications: eliminate animals from food, fashion, and pharmaceuticals. The fund invests in alternative proteins from plants, microbes, and cells; next-generation non-animal materials for fashion and industrial use; and human organ-on-chip technology for drug discovery without animal testing. Fund size isn't publicly disclosed, but typical checks of $500K-$2M at seed and